Insurance and genetic testing : where are we now ?
Basic research will spur development of genetic tests that are capable of presymptomatic prediction of disease, disability, and premature death in presently asymptomatic individuals.
Concerns have been expressed about potential harms related to the use of genetic test results, especially loss of confidentiality, eugenics, and discrimination.
Existing laws and administrative policies may not be sufficient to assure that genetic information is used fairly.
To provide factual information and conceptual principles upon which sound social policy can be based, the Human Genome Initiative established an Ethical, Legal, and Social Issues Program.
Mots-clés Pascal : Diagnostic, Maladie héréditaire, Génétique, Asymptomatique, Assurance maladie, Législation, Ethique, Organisation santé, Homme
Mots-clés Pascal anglais : Diagnosis, Genetic disease, Genetics, Asymptomatic, Health insurance, Legislation, Ethics, Public health organization, Human
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 93-0546268
Code Inist : 002B23A. Création : 199406.